0001415889-18-001202.txt : 20180801 0001415889-18-001202.hdr.sgml : 20180801 20180801160526 ACCESSION NUMBER: 0001415889-18-001202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180801 DATE AS OF CHANGE: 20180801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curran Terrie CENTRAL INDEX KEY: 0001690298 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 18984746 MAIL ADDRESS: STREET 1: C/O MYOVANT SCIENCES INC. STREET 2: 320 WEST 37TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-08012018_040811.xml X0306 4 2018-07-30 0000816284 CELGENE CORP /DE/ CELG 0001690298 Curran Terrie C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 false true false false SEE REMARKS Stock Option (right to buy) 88.91 2018-07-30 4 A 0 12983 0 A 2028-07-30 Common Stock 12983 12983 D Option is immediately exercisable and will vest in four equal annual installments commencing on July 30, 2019. The option was issued pursuant to the Company's 2017 Stock Incentive Plan. President, Inflammation and Immunology /s/ Mark J. Alles, Attorney-in-Fact 2018-08-01